HYPR Hyperfine, Inc.

Nasdaq hyperfine.io


$ 1.30 $ -0.12 (-8.45 %)    

Friday, 17-Oct-2025 19:21:53 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.3
$ 1.42
$ 1.29 x 3
$ 1.54 x 100
$ 1.29 - $ 1.44
$ 0.53 - $ 2.22
1,145,708
na
102.16M
$ 0.86
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-13-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-17-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-22-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-14-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-22-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-25-2022 12-31-2021 10-K
16 11-18-2021 09-30-2021 10-Q
17 08-19-2021 06-30-2021 10-Q
18 05-17-2021 03-31-2021 10-Q
19 03-29-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hyperfine-sees-q3-sales-3400m-vs-3507m-est

Hyperfine (NASDAQ:HYPR) sees Q3 sales of $3.400 million vs $3.507 million analyst estimate.

 hyperfine-secures-ce-and-ukca-approvals-for-optive-ai-advancing-image-quality-for-portable-mri-across-europe

Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European marketsHy...

 wells-fargo-maintains-equal-weight-on-hyperfine-raises-price-target-to-085

Wells Fargo analyst Larry Biegelsen maintains Hyperfine (NASDAQ:HYPR) with a Equal-Weight and raises the price target from $...

 lake-street-maintains-buy-on-hyperfine-raises-price-target-to-2

Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $1.5 to $2.

 hyperfine-affirms-fy2025-sales-guidance-of-14179m-15468m-vs-14193m-est

Hyperfine (NASDAQ:HYPR) affirms FY2025 sales outlook from $14.179 million-$15.468 million to $14.179 million-$15.468 million vs...

 hyperfine-q2-eps-012-inline-sales-2696m-miss-3000m-estimate

Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.2...

 hyperfine-announces-enrollment-of-100-patients-in-neuro-pmr-study-just-16-weeks-after-study-initiation-announced-on-april-15-2025

NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingHyperf...

 hyperfine-launches-prime-study-to-evaluate-ai-powered-portable-mri-in-emergency-department-triage

The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED setting...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION